Expertise in
13
conditions

Avivit Brener

6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 
Expertise in
13
conditions
6 Weizmann Street, 6423906, 
Tel Aviv, TA, IL 

Overview

Avivit Brener practices practicing medicine in Tel Aviv, Israel.

Brener is highly rated in 13 conditions, according to our data. Their clinical expertise encompasses Type 1 Diabetes (T1D), Congenital Hyperinsulinism, X-Linked Hypophosphatemia, Hypophosphatemia, and Adenoidectomy.

They are actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 7 clinical trials.

Locations

6 Weizmann Street, 6423906, Tel Aviv, TA 64239, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
Enrollment Status: Completed
Publish Date: February 22, 2022
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Feasibility Study to Evaluate the Hybrid-Logic Closed Loop System in Type 1 Diabetes -Single-arm, Single-center, in Clinic Study-The DREAMED Trail
Enrollment Status: Completed
Publish Date: January 02, 2020
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
Enrollment Status: Withdrawn
Publish Date: December 30, 2019
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study
Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study
Enrollment Status: Terminated
Publish Date: December 21, 2018
Intervention Type: Other, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

77 Total Publications

Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth With Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up.
Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth With Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: May 24, 2026

Frequently Asked Questions about Avivit Brener

Is Avivit Brener a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Avivit Brener is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Avivit Brener participate in research or clinical trials?

Yes. Avivit Brener has published 77 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Avivit Brener's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Brener's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile